In Case You Missed It
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Biotechs were trading at high volumes Thursday morning on news that the Senate has passed the 21st Century Cures Act.
Shares of Mallinckrodt were lower on Tuesday, despite posting better than expected fourth-quarter revenue and profits.
The pharmaceutical company saw shares fall more than 8% Tuesday.
The Nasdaq rose 0.7% to an all-time high of 5,403. The S&P 500 was up 0.3%, and the Dow Jones Industrial Average gained 0.2%.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.